Clinical outcomes and survival differences between primary, secondary and concomitants carcinoma in situ of urinary bladder treated with BCG immunotherapy

BACKGROUND: The carcinoma in situ (CIS) of urinary bladder is a flat, high-grade and aggressive manifestation of urothelial cancer which carries a great risk for progression to muscle invasive disease and metastatic spread. The aim of the study was to analyse the clinical history and survival differ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Androl Urol
Main Authors: Piszczek, Radosław, Krajewski, Wojciech, Małkiewicz, Bartosz, Krajewski, Piotr, Tukiendorf, Andrzej, Zdrojowy, Romuald, Kołodziej, Anna
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7354324/
https://ncbi.nlm.nih.gov/pubmed/32676418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau.2020.03.40
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados